Close Menu

University of Southampton

The researchers hope the datasets from their study can help to explain the effects of disease-associated variants on specific cell types of the immune system.

Similar Survival

Lancet Oncology study finds that young BRCA-positive breast cancer patients have similar survival rates as non-carrier patients, the BBC reports.

Four SNPs at three sites in the genome showed potential associations with breast cancer outcomes in a GWAS meta-analysis involving more than 6,000 individuals. 

While point-of-care molecular testing of patients with respiratory illness wasn't associated with lower antibiotic use, patients tested had shorter drug courses.

The method offers a way for genome-wide arrays to be used in individual patients to uncover methylated sites associated with rare genomic imprinting disorders.

A multistage GWAS suggests inherited SNPs at four sites in the genome can contribute to the risk of developing myeloproliferative neoplasms.

SlipChip

New micro-device is inexpensive to manufacture and can run nucleic acid amplification at room temperature.

NEW YORK (GenomeWeb) – Protea Biosciences Group today said that it has signed an agreement to collaborate with the University of Southampton to identify biomarkers that may indicate a risk of developing Alzheimer's disease.

LGC, in collaboration with the University of Southampton, has developed a panel of 24 scientifically-validated KASP genotyping assays that enables identification of human samples based on a genotyping profile, the partners said this week.

NEW YORK (GenomeWeb News) – The European Commission has provided €9 million ($11.9 million) to fund a multinational project that will use DNA sequencing to identify traits in certain plants that enable them to better withstand drought.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.